Deleterious BRCA2 Gene Mutation
specificA change in the nucleotide sequence of the BRCA2 gene that is associated with increased risk of disease.
48
Centers
7
Active Trials
—
Cancer Funding
Top Centers for Deleterious BRCA2 Gene Mutation(48)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 70.3 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center | 70.3 |
| 3 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive High-Volume Research Center | 70.3 |
| 4 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive High-Volume Research Center | 70.3 |
| 5 | University of Illinois Cancer CenterChicago, IL High-Volume Research Center | 70.3 |
| 6 | Boston University Cancer CenterBoston, MA High-Volume Research Center | 70.3 |
| 7 | Cancer Center at IllinoisUrbana, IL High-Volume Research Center | 70.3 |
| 8 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 47.8 |
| 9 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive | 47.8 |
| 10 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 47.8 |
| 11 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive | 47.8 |
| 12 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 47.8 |
| 13 | NCI Comprehensive | 47.8 |
| 14 | NCI Comprehensive | 47.8 |
| 15 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 47.8 |
| 16 | NCI Comprehensive | 47.8 |
| 17 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 47.8 |
| 18 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 47.8 |
| 19 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive | 47.8 |
| 20 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 47.8 |
| 21 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 47.8 |
| 22 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 47.8 |
| 23 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive | 47.8 |
| 24 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 47.8 |
| 25 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | 47.8 |
| 26 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 47.8 |
| 27 | NCI Clinical | 47.8 |
| 28 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 47.8 |
| 29 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 47.8 |
| 30 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive | 47.8 |
| 31 | UMass Memorial Health Cancer CenterWorcester, MA | 47.8 |
| 32 | Cleveland Clinic Cancer CenterCleveland, OH | 47.8 |
| 33 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 47.8 |
| 34 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive | 47.8 |
| 35 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical | 47.8 |
| 36 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive | 47.8 |
| 37 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR | 47.8 |
| 38 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 47.8 |
| 39 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 47.8 |
| 40 | 47.8 | |
| 41 | Penn State Cancer InstituteHershey, PA | 47.8 |
| 42 | University of Cincinnati Cancer CenterCincinnati, OH | 47.8 |
| 43 | Georgia Cancer Center, Augusta UniversityAugusta, GA | 47.8 |
| 44 | The University of Vermont Cancer CenterBurlington, VT | 47.8 |
| 45 | University of Texas Medical Branch Cancer CenterGalveston, TX | 47.8 |
| 46 | Loma Linda University Cancer CenterLoma Linda, CA | 47.8 |
| 47 | 47.8 | |
| 48 | Louisiana Cancer Research CenterNew Orleans, LA | 47.8 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →